Gerresheimer stock gains analyst backing as JP Morgan reiterates Overweight

Gerresheimer stock (ISIN DE000A0LD6E6) closed at EUR 28.22 on Xetra on September 7, 2026, down 0.21 percent from the previous day’s finish at EUR 28.28 per share, underlining the packaging specialist’s subdued short term share performance ahead of fresh analyst commentary, according to a recent market wrap summarized on September 9, 2026.

JP Morgan reiterates Overweight on Gerresheimer

Analyst support has strengthened the picture for Gerresheimer in recent days, with US bank JP Morgan reaffirming its Overweight stance on the company on September 9, 2026, signaling continued confidence in the group’s earnings trajectory despite the modest pullback in the share price, as reported by Ad-hoc-news.

According to an analyst overview from wallstreet-online on September 9, 2026, the JP Morgan analyst team led by Anchal Verma and David Adlington remains cautious on the broader European medtech sector but sees room for Gerresheimer to improve its revenue growth over a twelve month horizon, which supports the Overweight rating.

Deutsche Bank and other houses take a more cautious view

The analyst consensus around Gerresheimer remains mixed, with some houses expressing a more cautious stance despite JP Morgan’s positive view. Deutsche Bank Research kept its rating on Gerresheimer at Hold with a price target of EUR 26.00 on September 1, 2026, arguing that the specialist packaging manufacturer is still on a long path back to sustained stability, according to an analysis cited by finanzen.net.

In that same finanzen.net overview, Deutsche Bank’s EUR 26.00 target implies a downside of 12.10 percent compared with a referenced Gerresheimer price of EUR 29.58 at the time of the analysis, underscoring that the bank sees limited upside from current levels and expects valuation to remain under some pressure if the operational recovery is slower than anticipated.

The analyst table on finanzen.net also highlights that other houses such as Berenberg, UBS and Jefferies have recently rated Gerresheimer between Hold, Neutral and Overweight during late August and early September 2026, which suggests a broad range of views on how quickly the company can translate its order book and product portfolio into stronger revenue growth and margin expansion, according to finanzen.net.

Stock level and valuation context

Per the recent market commentary, Gerresheimer shares were quoted around EUR 29.04 in the JP Morgan related analysis snapshot compared with an earlier reference level of EUR 28.80, pointing to an increase of EUR 0.24 over that period and illustrating that the reiterated Overweight stance coincided with a modest recovery in the stock price, as noted by Ad-hoc-news.

The price references of EUR 28.22 as of September 7, 2026, and EUR 29.58 in the Deutsche Bank context indicate that Gerresheimer stock is trading within a relatively narrow band in the high twenties in recent sessions, leaving the shares above the level that Deutsche Bank considers fair value but still in a range that JP Morgan views as offering upside potential if the company can deliver stronger revenue growth and improve its earnings and cash flow profile.

For investors, the divergence between the EUR 26.00 Hold target from Deutsche Bank and the constructive Overweight view from JP Morgan is an important signal: the downside implied by the more cautious house suggests that execution risk and sector headwinds remain a factor, while the expectation of gradually improving growth and profitability used by JP Morgan highlights that Gerresheimer’s valuation could benefit if upcoming quarterly figures confirm the trajectory.

Closing price signal for Gerresheimer stock

Gerresheimer stock thus enters the next trading sessions with a recent Xetra closing level of EUR 28.22 on September 7, 2026, and analyst price references around EUR 26.00 to EUR 29.58 framing the current valuation corridor in the eyes of major banks, giving investors a concrete range to watch as new company data and sector developments emerge.

More news and analyses on Gerresheimer stock